Drägerwerk with political warning, shares trade weaker in SDAX and TecDAX
22.06.2026 - 19:14:25 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 19:10.
Drägerwerk (DE0005550636) faces a muted session on Xetra after its chief executive criticized German economic policy, with the preferred shares at times trading below 82 euros according to intraday data. The SDAX and TecDAX member thus combines a political warning with a weaker share price on Monday.
What Reuters and others report
Chief executive Stefan Dräger urged German politicians to avoid sudden shifts in economic policy and to deliver more continuity in reforms, according to a report that draws on his comments to dpa and other outlets on June 22. The manager warned that abrupt U-turns on topics such as energy policy and regulation complicate long-term planning for industrial groups like Drägerwerk, which supplies hospitals and safety customers worldwide, a point also highlighted in a MarketScreener summary of the remarks.
Investors reacted cautiously to the political critique, with the Drägerwerk preferred shares losing around 2.8 percent to about 81.90 euros on Xetra in early afternoon trading on June 22, as reported by finanzen.at in its market coverage. That move reflects a phase of consolidation after a previously strong 12-month performance.
Analyst stance and recent performance
On a 12-month view the Drägerwerk shares still show a robust gain of more than 20 percent, but the recent month has brought a decline of about 11 percent and a loss of more than 8 percent over the last week, according to data compiled by wallstreet-online for the SDAX and TecDAX listings. The shares currently trade roughly 15 percent below their 52-week high, while still about 35 percent above the 52-week low, as the same wallstreet-online performance overview shows.
The analyst community remains cautious rather than euphoric, with an average price target near 80 euros from several houses, implying only limited downside versus levels around 82 euros, as indicated by aggregated estimates on MarketScreener and other platforms. Jefferies most recently reiterated a Hold rating and lifted its target to 90 euros on May 28, according to a MarketScreener analyst snapshot, underscoring that the stock now sits between near-term chart pressure and fundamentally improved earnings power.
All news and analysis on the Drägerwerk shares
Key figures, background and further ad hoc reports on Drägerwerk can be found bundled in the dedicated topic section and on the company’s Investor Relations pages.
The product behind the stock
Drägerwerk generates its revenue primarily with medical and safety technology, ranging from ventilators and anesthesia workstations to gas detection systems and personal protective equipment. A flagship product line is its hospital ventilators, which are used in intensive care units worldwide for patients requiring reliable respiratory support.
Where the stock trades today
The Drägerwerk preferred shares (DE0005550636) trade on Xetra at 82.00 euros as of 2026-06-22, 17:14, according to real-time data, valuing the company clearly in the mid-cap range on the German market.
Drägerwerk at a glance
- Company: Drägerwerk AG & Co. KGaA
- ISIN: DE0005550636
- WKN: 555063
- Ticker: DRW3
- Trading venue: Xetra
- Price (as of 2026-06-22, 17:14): 82.00 EUR
- Market cap: 1.32 billion EUR (as of 2026-06-22)
- Sector / industry: Health care equipment and supplies
- Index membership: SDAX, TecDAX
- Next earnings date: 2026-07-30
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.
